Placental mesenchymal dysplasia (PMD) is characterized by multiple hypoechoic vesicles which are similar to molar changes in the placenta; however, the process of such morphological changes of PMD during pregnancy has not been fully understood. We performed a review of all PMD cases published in English and identified 49 articles including 110 cases. With regard to the gestational age at which the multicystic pattern was seen, approximately 70% of cases were diagnosed at 13-20 weeks of gestation. Another characteristic feature of PMD is varicose dilation of fetal chorionic vessels. As many as 90% of cases were diagnosed as placenta with dilated fetal chorionic vessels in the third trimester. We also report a case of PMD which was found at 10 weeks of gestation according to ultrasonic molar patterns. Serial observations of the placenta using ultrasound and magnetic resonance imaging revealed that multicystic lesions became smaller after 23 weeks. In contrast, dilated placental vessels on the fetal side became apparent at 38 weeks. The present review highlights that placental vesicular lesions of PMD may precede dilation of fetal chorionic vessels during pregnancy. It also indicates the potential of a gradual reduction in size of PMD's placental vesicular lesions by serial study of placental images.

Keywords:
Placental mesenchymal dysplasia, Ultrasound, Magnetic resonance imaging
1.
Heazell AE, Sahasrabudhe N, Grossmith AK, Martindale EA, Bhatia K: A case of intrauterine growth restriction in association with placental mesenchymal dysplasia with abnormal placental lymphatic development. Placenta 2009;30:654-657.
2.
Chan YF, Sampson A: Placental mesenchymal dysplasia: a report of four cases with differentiation from partial hydatidiform mole. Aust NZ J Obstet Gynaecol 2003;43:475-479.
3.
Jauniaux E, Nicolaides KH, Hustin J: Perinatal features associated with placental mesenchymal dysplasia. Placenta 1997;18:701-706.
4.
Arizawa M, Nakayama M: Suspected involvement of the X chromosome in placental mesenchymal dysplasia. Congenit Anom (Kyoto) 2002;42:309-317.
5.
Hillstrom MM, Brown DL, Wilkins-Haug L, Genest DR: Sonographic appearance of placental villous hydrops associated with Beckwith-Wiedemann syndrome. J Ultrasound Med 1995;14:61-64.
6.
Lage JM: Placentomegaly with massive hydrops of placental stem villi, diploid DNA content, and fetal omphaloceles: possible association with Beckwith-Wiedemann syndrome. Hum Pathol 1991;22:591-597.
7.
McCowan LM, Becroft DM: Beckwith-Wiedemann syndrome, placental abnormalities, and gestational proteinuric hypertension. Obstet Gynecol 1994;83:813-817.
8.
Paradinas FJ, Sebire NJ, Fisher RA, Rees HC, Foskett M, Seckl MJ, Newlands ES: Pseudo-partial moles: placental stem vessel hydrops and the association with Beckwith-Wiedemann syndrome and complete moles. Histopathology 2001;39:447-454.
9.
Takayama M, Soma H, Yaguchi S, Funayama H, Fujiwara K, Irie H, Yamane S: Abnormally large placenta associated with Beckwith-Wiedemann syndrome. Gynecol Obstet Invest 1986;22:165-168.
10.
H'mida D, Gribaa M, Yacoubi T, Chaieb A, Adala L, Elghezal H, Saad A: Placental mesenchymal dysplasia with Beckwith-Wiedemann syndrome fetus in the context of biparental and androgenic cell lines. Placenta 2008;29:454-460.
11.
Chen CP, Chern SR, Wang TY, Huang ZD, Huang MC, Chuang CY: Pregnancy with concomitant chorangioma and placental vascular malformation with mesenchymal hyperplasia. Human Reprod 1997;12:2533-2556.
12.
Cohen MC, Roper EC, Sebire NJ, Stanek J, Anumba DO: Placental mesenchymal dysplasia associated with fetal aneuploidy. Prenat Diagn 2005;25:187-192.
13.
Kaiser-Rogers KA, McFadden DE, Livasy CA, Dansereau J, Jiang R, Knops JF, Lefebvre L, Rao KW, Robinson WP: Androgenetic/biparental mosaicism causes placental mesenchymal dysplasia. J Med Genet 2006;43:187-192.
14.
Lee GK, Chi JG, Cha KS: An unusual venous anomaly of the placenta. Am J Clin Pathol 1991;95:48-51.
15.
Ohyama M, Kojyo T, Gotoda H, Sato T, Ijiri R, Tanaka Y: Mesenchymal dysplasia of the placenta. Pathol Int 2000;50:759-764.
16.
Pridmore BR, Khong TY, Wells WA: Ultrasound placental cysts associated with massive placental stem villous hydrops, diploid DNA content, and exomphalos. Am J Perinatol 1994;11:14-18.
17.
Sander CM: Angiomatous malformation of placental chronic stem vessels and pseudo-partial molar placentas: report of five cases. Pediatr Pathol 1993;13:621-633.
18.
Pham T, Steele J, Stayboldt C, Chan L, Benirschke K: Placental mesenchymal dysplasia is associated with high rates of intrauterine growth restriction and fetal demise: a report of 11 new cases and review of the literature. Am J Clin Pathol 2006;126:67-78.
19.
Jalil SSA, Mahran MA, Sule M: Placental mesenchymal dysplasia: can it be predicted prenatally? A case report. Prenat Diagn 2009;29:713-714.
20.
Vaisbuch E, Romero R, Kusanovic JP, Erez O, Mazaki-Tovi S, Gotsch F, Kim CJ, Kim JS, Yeo L, Hassan SS: Three-dimensional sonographic imaging of placental mesenchymal dysplasia and its differential diagnosis. J Ultrasound Med 2009;28:359-368.
21.
Aviram R, Kidron D, Silverstein S, Lerer I, Abeliovich D, Tepper R, Dolfin Z, Markovitch O, Arnon S: Placental mesenchymal dysplasia associated with transient neonatal diabetes mellitus and paternal UPD6. Placenta 2008;29:646-649.
22.
Robinson WP, Lauzon JL, Innes AM, Lim K, Arsovska S, McFadden DE: Origin and outcome of pregnancies affected by androgenetic/biparental chimerism. Hum Reprod 2007;22:1114-1122.
23.
Kinoshita T, Fukaya S, Yasuda Y, Itoh M: Placental mesenchymal dysplasia. J Obstet Gynaecol Res 2007;33:83-86.
24.
Reed RC, Beischel L, Schoof J, Johnson J, Raff ML, Kapur RP: Androgenic/biparental mosaicism in an infant with hepatic mesenchymal hamartoma and placental mesenchymal dysplasia. Pediatr Dev Pathol 2008;11:377-383.
25.
Robinson WP, Slee J, Smith N, Murch A, Watson SK, Lam WL, McFadden DE: Placental mesenchymal dysplasia associated with fetal overgrowth and mosaic deletion of the maternal copy of 11p15.5. Am J Med Genet A 2007;143A:1752-1759.
26.
Tortoledo M, Galindo A, Ibarrola C: Placental mesenchymal dysplasia associated with hepatic and pulmonary hamartoma. Fetal Pediatr Pathol 2010;29:261-270.
27.
Feinberg RF, Lockwood CJ, Salafia C, Hobbins JC: Sonographic diagnosis of a pregnancy with a diffuse hydatidiform mole and coexistent 46,XX fetus: a case report. Obstet Gynaecol 1988;72:485-488.
28.
Furuhashi M, Oda H, Nakashima T: Hydrops of placental stem villi complicated with fetal congenital adrenal hyperplasia. Arch Gynecol Obstet 2000;264:101-104.
29.
Müngen E, Dundar Ö, Muhcu M, Haholu A, Tunca Y: Placental mesenchymal dysplasia associated with trisomy 13: sonographic findings. J Clin Ultrasound 2008;36:454-456.
30.
Ang DC, Urrego PAR, Prasad V: Placental mesenchymal dysplasia: a potential misdiagnosed entity. Arch Gynecol Obstet 2009;279:937-939.
31.
Schuetzle MN, Uphoff TS, Hatten BA, Dawson DB: Utility of microsatellite analysis in evaluation of pregnancies with placental mesenchymal dysplasia. Prenat Diagn 2007;27:1238-1244.
32.
Wilson M, Peters G, Bennetts B, McGillivray G, Wu ZH, Poon C, Algar E: The clinical phenotype of mosaicism for genome-wide paternal uniparental disomy: two new reports. Am J Med Genet A 2008;146A:137-148.
33.
Morales C, Soler A, Badenas C, Rodríguez-Revenga L, Nadal A, Martínez JM, Mademont-Soler I, Borrell A, Mirà M, Sánchez A: Reproductive consequences of genome-wide paternal uniparental disomy mosaicism: description of two cases with different mechanisms of origin and pregnancy outcomes. Fertil Steril 2009;92:393.e5-e9.
34.
Kitano Y, Ruchelli E, Weiner S, Adzick NS: Hepatic mesenchymal hamartoma associated with mesenchymal stem villous hyperplasia of the placenta. Fetal Diagn Ther 2000;15:134-138.
35.
Moscoso G, Jauniaux E, Hustin J: Placental vascular anomaly with diffuse mesenchymal stem villous hyperplasia: a new clinico-pathological entity? Path Res Pract 1991;187:324-328.
36.
Højberg KE, Aagaard J, Henriques U, Sunde L: Placental vascular malformation with mesenchymal hyperplasia and a localized chorioangioma: a rarity simulating partial mole. Path Res Pract 1994;190:808-813.
37.
Matsui H, Iitsuka Y, Yamazawa K, Tanaka N, Mitsuhashi A, Seki K, Sekiya S: Placental mesenchymal dysplasia initially diagnosed as partial mole. Pathol Int 2003;53:810-813.
38.
Gibson BR, Muir-Padilla J, Champeaux A, Suarez ES: Mesenchymal dysplasia of the placenta. Placenta 2004;25:671-672.
39.
Hoffner L, Dunn J, Esposito N, Macpherson T, Surti U: p57KIP2 immunostaining and molecular cytogenetics: combined approach aids in diagnosis of morphologically challenging cases with molar phenotype and in detecting androgenetic cell lines in mosaic/chimeric conceptions. Hum Pathol 2008;39:63-72.
40.
Francis B, Hallam L, Kecskes Z, Ellwood D, Croaker D, Kent A: Placental mesenchymal dysplasia associated with hepatic mesenchymal hamartoma in the newborn. Pediatr Dev Pathol 2007;10:50-54.
41.
Starikov R, Goldman R, Dizon DS, Kostadinov S, Carr S: Placental mesenchymal dysplasia presenting as a twin gestation with complete molar pregnancy. Obstet Gynecol 2011;118:445-449.
42.
Ruhland B, Schröer A, Gembruch U, Noack F, Weichert J: Prenatal imaging and postnatal pathologic work-up in a case of fetal hepatic hamartoma and placental mesenchymal dysplasia. Ultrasound Obstet Gynecol 2011;38:360-365.
43.
Mack-Detlefsen B, Bormers TM, Groneck P, Bald R: Multiple hepatic mesenchymal hamartomas in a premature associated with placental mesenchymal dysplasia. J Pediatr Surg 2011;46:E23-E25.
44.
Woo GW, Rocha FG, Gaspar-Oishi M, Bartholomew ML, Thompson KS: Placental mesenchymal dysplasia. Am J Obstet Gynecol 2011;205:e3-e5.
45.
Umazume T, Kataoka S, Kamamuta K, Tanuma F, Sumie A, Shirogane T, Kudou T, Ikeda H: Placental mesenchymal dysplasia, a case of intrauterine sudden death of fetus with rupture of cirsoid periumbilical chorionic vessels. Diagn Pathol 2011;6:38.
46.
Gizzo S, Gangi SD, Patrelli TS, Saccardi C, D'Antona D, Nardelli GB: Placental mesenchymal dysplasia: can early diagnosis ensure a good materno-foetal outcome? A case report. Arch Gynecol Obstet 2012;286:15-17.
47.
Zeng X, Chen MF, Bureau Y-A, Brown R: Placental mesenchymal dysplasia and an estimation of the population incidence. Acta Obstet Gynecol Scand 2012;91:754-757.
48.
Surti U, Hill LM, Dunn J, Prosen T, Hoffner L: Twin pregnancy with a chimeric androgenetic and biparental placenta in one twin displaying placental mesenchymal dysplasia phenotype. Prenat Diagn 2005;25:1048-1056.
49.
Mulch AD, Stallings SP, Salafia CM: Elevated maternal serum alpha-fetoprotein, umbilical vein varix, and mesenchymal dysplasia: are they related? Prenat Diagn 2006;26:659-661.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.